Waters’ Q2 Strength Earns a Place Among Madison’s Top Contributors
The fund cited solid results in Waters’ core business and newly acquired diagnostics operations as shares climbed over the past year.
Makkler Newsroom · Sep 23, 05:18 PM · 2 min read
Market closed· · USD · Data may be delayed
Avg. target $509.76 (+10.8%)
Prices may be delayed and are for informational purposes only - not investment advice.
The fund cited solid results in Waters’ core business and newly acquired diagnostics operations as shares climbed over the past year.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.